ArticleBMC psychiatry2025
Episodic memory and inhibitory control in people who inject substances results of cohort COSINUS study.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive disorders associated with addictive disorders are well established in the literature for numerous substances and behaviours. Very few studies have examined the effect of polydrug use on cognitive functioning. These studies have focused on the cognitive effect of one substance among others in very small samples. They did not take into account HCV/HIV infections, which are highly prevalent among polydrug users due to frequent injections and sharing of materials and whose impact on cognition is well documented. In our study, we aim to investigate two critical cognitive functions in the addiction process, memory and inhibitory control, in a population of people who inject substances (PWIS).
methodThanks to the COSINUS Cohort, we evaluated polydrug use of PWIS, inhibitory control, and memory in 383 PWIS by administering the Go/No-go test and the 5-word test. PWIS were recruited in drug consumption rooms (DCRs) and harm reduction facilities.
results93% of PWIS are polydrug users. Our findings demonstrate typical effects of substance use on memory, revealing a deficit associated with age, along with risky alcohol and cannabis use, while showing a potential benefit from the use of psychostimulants. We found a positive impact of educational level on impulsivity. PWIS who request job assistance and education training exhibit lower free recall compared to the others. HCV/HIV infections are associated with a negative effect on cognition, but the results are mixed. DCR attendance is associated with a positive effect on both memory and inhibitory control.
conclusionOur study confirms the importance of screening for cognitive deficits in polydrug users, improving specific treatment for cognitive deficits in PWIS through appropriate mental health care, and encouraging multidisciplinary harm reduction and psychiatry care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.